Abstract
Integrin β6 (ITGB6), a member of the integrin family of proteins, is only present in epithelial tissues and frequently associates with integrin subunit αv to form transmembrane heterodimers named integrin αvβ6. Importantly, ITGB6 determines αvβ6 expression and availability. In addition to being engaged in organ fibrosis, ITGB6 is also directly linked to the emergence of cancer, periodontitis, and several potential genetic diseases. Therefore, it is of great significance to study the molecular-biological mechanism of ITGB6, which could provide novel insights for future clinical diagnosis and therapy. This review introduces the structure, distribution, and biological function of ITGB6. This review also expounds on ITGB6-related diseases, detailing the known biological effects of ITGB6.
Similar content being viewed by others
Data Availability
Figures were partly generated using Servier Medical Art, provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license.
Abbreviations
- ITGB6:
-
Integrin β6
- ITGAV:
-
Integrin αv
- MMP:
-
Matrix metalloproteinase
- TGF-β1:
-
Transforming growth factor β-1
- BDEC:
-
Bile duct epithelial cells
- VSMC:
-
Vascular smooth muscle cells
- Elk1:
-
ETS domain-containing protein
- FAK:
-
Focal adhesion kinase
- EMT:
-
Epithelial-mesenchymal transformation
- FOXO1:
-
Forkhead box O-1
- STAT3:
-
Signal transducers and transcriptional of activator 3
References
Kechagia JZ, Ivaska J, Roca-Cusachs P (2019) Integrins as biomechanical sensors of the microenvironment. Nat Rev Mol Cell Biol 20:457–473. https://doi.org/10.1038/s41580-019-0134-2
Moreno-Layseca P, Icha J, Hamidi H, Ivaska J (2019) Integrin trafficking in cells and tissues. Nat Cell Biol 21:122–132. https://doi.org/10.1038/s41556-018-0223-z
Humphries MJ (2000) Integrin structure. Biochem Soc Trans 28:311–339
Takada Y, Ye X, Simon S (2007) The integrins. Genome Biol 8:215. https://doi.org/10.1186/gb-2007-8-5-215
Chen W, Harbeck MC, Zhang W, Jacobson JR (2013) MicroRNA regulation of integrins. Translational Research: The Journal of Laboratory and Clinical Medicine 162:133–143. https://doi.org/10.1016/j.trsl.2013.06.008
Molè MA, Weberling A, Fässler R, Campbell A, Fishel S, Zernicka-Goetz M (2021) Integrin β1 coordinates survival and morphogenesis of the embryonic lineage upon implantation and pluripotency transition. Cell Rep 34:108834. https://doi.org/10.1016/j.celrep.2021.108834
Sekheri M, Othman A, Filep JG (2021) β2 integrin regulation of Neutrophil Functional plasticity and fate in the resolution of inflammation. Front Immunol 12:660760. https://doi.org/10.3389/fimmu.2021.660760
Lainé A, Labiad O, Hernandez-Vargas H, This S, Sanlaville A, Léon S, Dalle S, Sheppard D, Travis MA, Paidassi H, Marie JC (2021) Regulatory T cells promote cancer immune-escape through integrin αvβ8-mediated TGF-β activation. Nat Commun 12:6228. https://doi.org/10.1038/s41467-021-26352-2
Pang X, He X, Qiu Z, Zhang H, **e R, Liu Z, Gu Y, Zhao N, **ang Q, Cui Y (2023) Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduct Target Therapy 8:1. https://doi.org/10.1038/s41392-022-01259-6
Fernández-Ruiz E, Sánchez-Madrid F (1994) Regional localization of the human integrin beta 6 gene (ITGB6) to chromosome 2q24-q31. Genomics 21:638–640. https://doi.org/10.1006/geno.1994.1325
Brzozowska E, Deshmukh S (2022) Integrin Alpha v Beta 6 (αvβ6) and its implications in Cancer Treatment. Int J Mol Sci 23. https://doi.org/10.3390/ijms232012346
Koivisto L, Bi J, Häkkinen L, Larjava H (2018) Integrin αvβ6: structure, function and role in health and Disease. Int J Biochem Cell Biol 99:186–196. https://doi.org/10.1016/j.biocel.2018.04.013
Morgan MR, Jazayeri M, Ramsay AG, Thomas GJ, Boulanger MJ, Hart IR, Marshall JF (2011) Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion. Oncogene 30:1422–1435. https://doi.org/10.1038/onc.2010.535
Duperret EK, Dahal A, Ridky TW (2015) Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and Tumor invasion. J Cell Sci 128:3997–4013. https://doi.org/10.1242/jcs.175539
Katoh D, Nagaharu K, Shimojo N, Hanamura N, Yamashita M, Kozuka Y, Imanaka-Yoshida K, Yoshida T (2013) Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of Breast cancer cells. Oncogenesis 2:e65. https://doi.org/10.1038/oncsis.2013.27
Dong X, Hudson NE, Lu C, Springer TA (2014) Structural determinants of integrin β-subunit specificity for latent TGF-β. Nat Struct Mol Biol 21:1091–1096. https://doi.org/10.1038/nsmb.2905
Paladino A, Civera M, Curnis F, Paolillo M, Gennari C, Piarulli U, Corti A, Belvisi L, Colombo G (2019) The importance of Detail: how differences in Ligand structures determine distinct functional responses in integrin α(v) β(3). Chemistry 25:5959–5970. https://doi.org/10.1002/chem.201900169
Cao D, Qi Z, Pang Y, Li H, **e H, Wu J, Huang Y, Zhu Y, Shen Y, Zhu Y, Dai B, Hu X, Ye D, Wang Z (2019) Retinoic acid-related orphan receptor C regulates proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer. Cancer Res 79:2604–2618. https://doi.org/10.1158/0008-5472.Can-18-3842
Xu M, Chen X, Yin H, Yin L, Liu F, Fu Y, Yao J, Deng X (2015) Cloning and characterization of the human integrin β6 gene promoter. PLoS ONE 10:e0121439. https://doi.org/10.1371/journal.pone.0121439
Dixit RB, Chen A, Chen J, Sheppard D (1996) Identification of a sequence within the integrin beta6 subunit cytoplasmic domain that is required to support the specific effect of alphavbeta6 on proliferation in three-dimensional culture. J Biol Chem 271:25976–25980. https://doi.org/10.1074/jbc.271.42.25976
Zhang Y, Sun Y, Yang F, Guo J, He J, Wu Q, Cao W, Lv L, Zheng H, Zhang Z (2013) Induction of partial protection against foot and mouth Disease virus in guinea pigs by neutralization with the integrin β6 – 1 subunit. Viruses 5:1114–1130. https://doi.org/10.3390/v5041114
Koth LL, Alex B, Hawgood S, Nead MA, Sheppard D, Erle DJ, Morris DG (2007) Integrin beta6 mediates phospholipid and collectin homeostasis by activation of latent TGF-beta1. Am J Respir Cell Mol Biol 37:651–659. https://doi.org/10.1165/rcmb.2006-0428OC
Niu J, Li Z (2017) The roles of integrin αvβ6 in cancer. Cancer Lett 403:128–137. https://doi.org/10.1016/j.canlet.2017.06.012
Mori H, Lo AT, Inman JL, Alcaraz J, Ghajar CM, Mott JD, Nelson CM, Chen CS, Zhang H, Bascom JL, Seiki M, Bissell MJ (2013) Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin β1. Development 140:343–352. https://doi.org/10.1242/dev.084236
Tod J, Hanley CJ, Morgan MR, Rucka M, Mellows T, Lopez MA, Kiely P, Moutasim KA, Frampton SJ, Sabnis D, Fine DR, Johnson C, Marshall JF, Scita G, Jenei V, Thomas GJ (2017) Pro-migratory and TGF-β-activating functions of αvβ6 integrin in Pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch. J Pathol 243:37–50. https://doi.org/10.1002/path.4923
Lian PL, Liu Z, Yang GY, Zhao R, Zhang ZY, Chen YG, Zhuang ZN, Xu KS (2016) Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. World J Gastroenterol 22:3852–3859. https://doi.org/10.3748/wjg.v22.i14.3852
Zhu H, Liao J, Zhou X, Hong X, Song D, Hou FF, Liu Y, Fu H (2020) Tenascin-C promotes acute kidney injury to chronic Kidney Disease progression by impairing tubular integrity via αvβ6 integrin signaling. Kidney Int 97:1017–1031. https://doi.org/10.1016/j.kint.2020.01.026
Ciregia F, Deroyer C, Cobraiville G, Plener Z, Malaise O, Gillet P, Fillet M, Malaise MG, de Seny D (2021) Modulation of α(V)β(6) integrin in osteoarthritis-related synovitis and the interaction with VTN((381–397 a.a.)) competing for TGF-β1 activation. Exp Mol Med 53:210–222. https://doi.org/10.1038/s12276-021-00558-2
Elosegui-Artola A, Bazellières E, Allen MD, Andreu I, Oria R, Sunyer R, Gomm JJ, Marshall JF, Jones JL, Trepat X, Roca-Cusachs P (2014) Rigidity sensing and adaptation through regulation of integrin types. Nat Mater 13:631–637. https://doi.org/10.1038/nmat3960
Meecham A, Marshall JF (2020) The ITGB6 gene: its role in experimental and clinical biology. Gene X 5:100023. https://doi.org/10.1016/j.gene.2019.100023
Bi J, Koivisto L, Dai J, Zhuang D, Jiang G, Larjava M, Shen Y, Bi L, Liu F, Haapasalo M, Häkkinen L, Larjava H (2019) Epidermal growth factor receptor signaling suppresses αvβ6 integrin and promotes periodontal inflammation and bone loss. J Cell Sci 133. https://doi.org/10.1242/jcs.236588
Zhang Y, Lu W, Zhang X, Lu J, Xu S, Chen S, Zhong Z, Zhou T, Wang Q, Chen J, Liu P (2019) Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways. Pharmacol Res 147:104307. https://doi.org/10.1016/j.phrs.2019.104307
Dong X, Zhao B, Lin FY, Lu C, Rogers BN, Springer TA (2018) High integrin α(V)β(6) affinity reached by hybrid domain deletion slows ligand-binding on-rate. Proc Natl Acad Sci USA 115:E1429–e1436. https://doi.org/10.1073/pnas.1718662115
Campbell ID, Humphries MJ (2011) Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol 3. https://doi.org/10.1101/cshperspect.a004994
Henderson NC, Rieder F, Wynn TA (2020) Fibrosis: from mechanisms to medicines. Nature 587:555–566. https://doi.org/10.1038/s41586-020-2938-9
Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic Disease. Nat Med 18:1028–1040. https://doi.org/10.1038/nm.2807
Tatler AL, Habgood A, Porte J, John AE, Stavrou A, Hodge E, Kerama-Likoko C, Violette SM, Weinreb PH, Knox AJ, Laurent G, Parfrey H, Wolters PJ, Wallace W, Alberti S, Nordheim A, Jenkins G (2016) Reduced ets domain-containing protein Elk1 promotes pulmonary fibrosis via increased integrin αvβ6 expression. J Biol Chem 291:9540–9553. https://doi.org/10.1074/jbc.M115.692368
**e H, Jiao Y, Zhou X, Liao X, Chen J, Chen H, Chen L, Yu S, Deng Q, Sun L, Xu X, Wang J (2022) Integrin αvβ6 contributes to the development of intestinal fibrosis via the FAK/AKT signaling pathway. Exp Cell Res 411:113003. https://doi.org/10.1016/j.yexcr.2021.113003
Chen L, Zhou T, White T, O’Brien A, Chakraborty S, Liangpunsakul S, Yang Z, Kennedy L, Saxena R, Wu C, Meng F, Huang Q, Francis H, Alpini G, Glaser S (2021) The apelin-apelin receptor Axis triggers Cholangiocyte Proliferation and Liver Fibrosis during Mouse models of Cholestasis. Hepatology (Baltimore MD) 73:2411–2428. https://doi.org/10.1002/hep.31545
Guillot A, Guerri L, Feng D, Kim SJ, Ahmed YA, Paloczi J, He Y, Schuebel K, Dai S, Liu F, Pacher P, Kisseleva T, Qin X, Goldman D, Tacke F, Gao B (2021) Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury. J Clin Investig 131. https://doi.org/10.1172/jci132305
Sullivan BP, Weinreb PH, Violette SM, Luyendyk JP (2010) The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis. Am J Pathol 177:2837–2849. https://doi.org/10.2353/ajpath.2010.100425
Sullivan BP, Cui W, Copple BL, Luyendyk JP (2012) Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice. Toxicol Sci 126:267–274. https://doi.org/10.1093/toxsci/kfr311
Hu J, Zeng X, Yuan X (2019) Fetal carotid-jugular fistula: a case report. Med (Baltim) 98:e16250. https://doi.org/10.1097/md.0000000000016250
Kwon SS, Park BW, Lee MH, Goo DE, Nam BD (2020) Right Heart Failure due to arteriovenous fistula after lumbar spine Surgery. Korean J Intern Med 35:1022–1023. https://doi.org/10.3904/kjim.2018.443
Zhang Y, Yi J, Zhang R, Peng Y, Dong J, Sha L (2022) Risk factors for arteriovenous fistula Thrombus development: a systematic review and Meta-analysis. Kidney Blood Press Res 47:643–653. https://doi.org/10.1159/000526768
Liu CT, Hsu SC, Hsieh HL, Chen CH, Chen CY, Sue YM, Lin FY, Shih CM, Shiu YT, Huang PH (2021) Parathyroid hormone induces transition of myofibroblasts in Arteriovenous Fistula and increases maturation failure. Endocrinology 162. https://doi.org/10.1210/endocr/bqab044
Liu CT, Hsu SC, Hsieh HL, Chen CH, Chen CY, Sue YM, Chen TH, Hsu YH, Lin FY, Shih CM, Shiu YT, Huang PH (2022) Inhibition of β-catenin signaling attenuates arteriovenous fistula thickening in mice by suppressing myofibroblasts. Mol Med 28:7. https://doi.org/10.1186/s10020-022-00436-1
Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, Yang Z, Devitt ML, Horan GS, Weinreb PH, Lukashev ME, Violette SM, Grant KS, Colarossi C, Formenti SC, Munger JS (2008) Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med 177:82–90. https://doi.org/10.1164/rccm.200706-806OC
Tatler AL, Goodwin AT, Gbolahan O, Saini G, Porte J, John AE, Clifford RL, Violette SM, Weinreb PH, Parfrey H, Wolters PJ, Gauldie J, Kolb M, Jenkins G (2016) Amplification of TGFβ Induced ITGB6 gene transcription may promote pulmonary fibrosis. PLoS ONE 11:e0158047. https://doi.org/10.1371/journal.pone.0158047
Zheng YJ, Li X, Sun L, Guo JW (2019) [Therapeutic effect of dihydroartemisinin on pulmonary fibrosis in rats with dust]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 37:96–103. https://doi.org/10.3760/cma.j.issn.1001-9391.2019.02.003
Chen H, Chen L, Wang X, Ge X, Sun L, Wang Z, Xu X, Song Y, Chen J, Deng Q, **e H, Chen T, Chen Y, Ding K, Wu J, Wang J (2021) Transgenic overexpression of ITGB6 in intestinal epithelial cells exacerbates dextran sulfate sodium-induced Colitis in mice. J Cell Mol Med 25:2679–2690. https://doi.org/10.1111/jcmm.16297
Li X, Miao Y, Li T, Liu X, Xu L, Guo J, Yu X, Sun B, Zhu Y, Ai D, Chen L (2023) Integrin β6 mediates epithelial-mesenchymal transition in diabetic Kidney Disease. Mol Cell Endocrinol 572:111955. https://doi.org/10.1016/j.mce.2023.111955
Bi J, Dai J, Koivisto L, Larjava M, Bi L, Häkkinen L, Larjava H (2019) Inflammasome and cytokine expression profiling in experimental periodontitis in the integrin β6 null mouse. Cytokine 114:135–142. https://doi.org/10.1016/j.cyto.2018.11.011
Uehara O, Bi J, Zhuang D, Koivisto L, Abiko Y, Häkkinen L, Larjava H (2022) Altered composition of the oral microbiome in integrin beta 6-deficient mouse. J Oral Microbiol 14:2122283. https://doi.org/10.1080/20002297.2022.2122283
Xu M, Huang J, Zhu F, Shen K, Liu F, Deng X (2022) FOXO1 inhibits FSL-1 regulation of integrin β6 by blocking STAT3 binding to the integrin β6 gene promoter. Front Cell Infect Microbiol 12:998693. https://doi.org/10.3389/fcimb.2022.998693
Seymen F, Lee KE, Koruyucu M, Gencay K, Bayram M, Tuna EB, Lee ZH, Kim JW (2015) Novel ITGB6 mutation in autosomal recessive amelogenesis imperfecta. Oral Dis 21:456–461. https://doi.org/10.1111/odi.12303
Ansar M, Jan A, Santos-Cortez RL, Wang X, Suliman M, Acharya A, Habib R, Abbe I, Ali G, Lee K, Smith JD, Nickerson DA, Shendure J, Bamshad MJ, Ahmad W, Leal SM (2016) Expansion of the spectrum of ITGB6-related disorders to adolescent alopecia, dentogingival abnormalities and intellectual disability. Eur J Hum Genet 24:1223–1227. https://doi.org/10.1038/ejhg.2015.260
Weil P, van den Bruck R, Ziegenhals T, Juranek S, Goedde D, Orth V, Wirth S, Jenke AC, Postberg J (2020) β6 integrinosis: a new lethal autosomal recessive ITGB6 disorder leading to impaired conformational transitions of the α(V)β6 integrin receptor. Gut 69:1359–1361. https://doi.org/10.1136/gutjnl-2019-319015
Roma M, Hegde P, Durga Nandhini M, Hegde S (2021) Management guidelines for amelogenesis imperfecta: a case report and review of the literature. J Med Case Rep 15:67. https://doi.org/10.1186/s13256-020-02586-4
Wang SK, Choi M, Richardson AS, Reid BM, Lin BP, Wang SJ, Kim JW, Simmer JP, Hu JC (2014) ITGB6 loss-of-function mutations cause autosomal recessive amelogenesis imperfecta. Hum Mol Genet 23:2157–2163. https://doi.org/10.1093/hmg/ddt611
Poulter JA, Brookes SJ, Shore RC, Smith CE, Abi Farraj L, Kirkham J, Inglehearn CF, Mighell AJ (2014) A missense mutation in ITGB6 causes pitted hypomineralized amelogenesis imperfecta. Hum Mol Genet 23:2189–2197. https://doi.org/10.1093/hmg/ddt616
Sriwattanapong K, Theerapanon T, Boonprakong L, Srijunbarl A, Porntaveetus T, Shotelersuk V (2023) Novel ITGB6 variants cause hypoplastic-hypomineralized amelogenesis imperfecta and taurodontism: characterization of tooth phenotype and review of literature. BDJ Open 9:15. https://doi.org/10.1038/s41405-023-00142-y
Lyu T, Jiang Y, Jia N, Che X, Li Q, Yu Y, Hua K, Bast RC Jr., Feng W (2020) SMYD3 promotes implant Metastasis of Ovarian cancer via H3K4 trimethylation of integrin promoters. Int J Cancer 146:1553–1567. https://doi.org/10.1002/ijc.32673
Zhuang H, Zhou Z, Ma Z, Li Z, Liu C, Huang S, Zhang C, Hou B (2020) Characterization of the prognostic and oncologic values of ITGB superfamily members in Pancreatic cancer. J Cell Mol Med 24:13481–13493. https://doi.org/10.1111/jcmm.15990
Li F, Shang Y, Shi F, Zhang L, Yan J, Sun Q, She J (2020) Expression of integrin β6 and HAX-1 correlates with aggressive features and poor prognosis in esophageal squamous cell carcinoma. Cancer Manag Res 12:9599–9608. https://doi.org/10.2147/cmar.S274892
Soejima Y, Takeuchi M, Miyamoto N, Sawabe M, Fukusato T (2021) ITGB6-Knockout suppresses Cholangiocarcinoma Cell Migration and Invasion with declining PODXL2 expression. Int J Mol Sci 22. https://doi.org/10.3390/ijms22126303
Xu M, Yin H, Cai Y, Huang W, Ji Q, Liu F, Shi S, Deng X (2019) Lysophosphatidic acid induces integrin β6 expression in human oral squamous cell carcinomas cells via LPAR1 coupling to Gα(i) and downstream SMAD3 and ETS-1 activation. Cell Signal 60:81–90. https://doi.org/10.1016/j.cellsig.2019.04.008
Xu M, Yin L, Cai Y, Hu Q, Huang J, Ji Q, Hu Y, Huang W, Liu F, Shi S, Deng X (2018) Epigenetic regulation of integrin β6 transcription induced by TGF-β1 in human oral squamous cell carcinoma cells. J Cell Biochem 119:4193–4204. https://doi.org/10.1002/jcb.26642
Zheng X, Zhu Y, Wang X, Hou Y, Fang Y (2021) Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway. Ann Transl Med 9:803. https://doi.org/10.21037/atm-21-1669
Sun Q, Shang Y, Sun F, Dong X, Niu J, Li F (2020) Interleukin-6 promotes epithelial-mesenchymal transition and Cell Invasion through Integrin β6 Upregulation in Colorectal Cancer. Oxidative Med Cell Longev 2020:8032187. https://doi.org/10.1155/2020/8032187
Deng W, Wang X, Chen L, Wen B, Chen Y, Ji K, Liu H (2022) Proteomic and miRNA profiles of Exosomes Derived from Myometrial Tissue in laboring women. Int J Mol Sci 23. https://doi.org/10.3390/ijms232012343
Krishn SR, Garcia V, Naranjo NM, Quaglia F, Shields CD, Harris MA, Kossenkov AV, Liu Q, Corey E, Altieri DC, Languino LR (2022) Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient Prostate cancer cells. Cancer Biol Ther 23:173–185. https://doi.org/10.1080/15384047.2022.2030622
Lenggenhager D, Bengs S, Fritsch R, Hussung S, Busenhart P, Endhardt K, Töpfer A, The FO, Bütikofer S, Gubler C, Scharl M, Morell B (2021) β6-Integrin serves as a potential serum marker for diagnosis and prognosis of pancreatic adenocarcinoma. Clin Transl Gastroenterol 12:e00395. https://doi.org/10.14309/ctg.0000000000000395
Bengs S, Becker E, Busenhart P, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, Mamie C, Vavricka SR, von Boehmer L, Knuth A, Tuomisto A, Mäkinen MJ, Hruz P, Turina M, Rickenbacher A, Petrowsky H, Weber A, Frei P, Halama M, Jenkins G, Sheppard D, Croner RS, Christoph J, Britzen-Laurent N, Naschberger E, Schellerer V, Stürzl M, Fried M, Rogler G, Scharl M (2019) β(6) -integrin serves as a novel serum Tumor marker for colorectal carcinoma. Int J Cancer 145:678–685. https://doi.org/10.1002/ijc.32137
Li Z, Sun Y, Xu J, Yang H, Liu X, Tian Y, Cao S, Zhou Y (2021) Integrin-β6 serves as a potential prognostic serum biomarker for gastric Cancer. Front Oncol 11:770997. https://doi.org/10.3389/fonc.2021.770997
Desai K, Nair MG, Prabhu JS, Vinod A, Korlimarla A, Rajarajan S, Aiyappa R, Kaluve RS, Alexander A, Hari PS, Mukherjee G, Kumar RV, Manjunath S, Correa M, Srinath BS, Patil S, Prasad MS, Gopinath KS, Rao RN, Violette SM, Weinreb PH, Sridhar TS (2016) High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers. Cancer Med 5:2000–2011. https://doi.org/10.1002/cam4.756
Bishop A, Cartwright JE, Whitley GS (2021) Stanniocalcin-1 in the female reproductive system and pregnancy. Hum Reprod Update 27:1098–1114. https://doi.org/10.1093/humupd/dmab028
Lin F, Li X, Wang X, Sun H, Wang Z, Wang X (2022) Stanniocalcin 1 promotes Metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in Ovarian cancer. J Exp Clin Cancer Res 41:129. https://doi.org/10.1186/s13046-022-02315-3
Kanaseki T, Tokita S, Torigoe T (2019) Proteogenomic discovery of cancer antigens: neoantigens and beyond. Pathol Int 69:511–518. https://doi.org/10.1111/pin.12841
MacNabb BW, Tumuluru S, Chen X, Godfrey J, Kasal DN, Yu J, Jongsma MLM, Spaapen RM, Kline DE, Kline J (2022) Dendritic cells can prime anti-tumor CD8(+) T cell responses through major histocompatibility complex cross-dressing. Immunity 55:982–997e988. https://doi.org/10.1016/j.immuni.2022.04.016
Overacre-Delgoffe AE, Bumgarner HJ, Cillo AR, Burr AHP, Tometich JT, Bhattacharjee A, Bruno TC, Vignali DAA, Hand TW (2021) Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against Colorectal cancer. Immunity 54:2812–2824e2814. https://doi.org/10.1016/j.immuni.2021.11.003
Busenhart P, Montalban-Arques A, Katkeviciute E, Morsy Y, Van Passen C, Hering L, Atrott K, Lang S, Garzon JFG, Naschberger E, Hartmann A, Rogler G, Stürzl M, Spalinger MR, Scharl M (2022) Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in Colorectal cancer. J Immunother Cancer 10. https://doi.org/10.1136/jitc-2021-003465
Galluzzi L, Humeau J, Buqué A, Zitvogel L, Kroemer G (2020) Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol 17:725–741. https://doi.org/10.1038/s41571-020-0413-z
Heinhuis KM, Ros W, Kok M, Steeghs N, Beijnen JH, Schellens JHM (2019) Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors. Ann Oncol 30:219–235. https://doi.org/10.1093/annonc/mdy551
Wang Y, Wang Z, Li K, **ang W, Chen B, ** L, Hao K (2022) lncRNAs functioned as ceRNA to Sponge miR-15a-5p affects the prognosis of pancreatic adenocarcinoma and correlates with Tumor Immune Infiltration. Front Genet 13:874667. https://doi.org/10.3389/fgene.2022.874667
McCabe EM, Rasmussen TP (2021) lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Sem Cancer Biol 75:38–48. https://doi.org/10.1016/j.semcancer.2020.12.012
Li W, Zhang B, Li H, Zhao C, Zhong Y, Sun J, Lv S (2014) TGF β1 mediates epithelial mesenchymal transition via β6 integrin signaling pathway in Breast cancer. Cancer Invest 32:409–415. https://doi.org/10.3109/07357907.2014.933235
Jiang Y, Zhou T, Shi Y, Feng W, Lyu T (2021) A SMYD3/ITGB6/TGFβ1 positive feedback Loop promotes the Invasion and Adhesion of Ovarian Cancer spheroids. Front Oncol 11:690618. https://doi.org/10.3389/fonc.2021.690618
Huang M, Lin Y, Wang C, Deng L, Chen M, Assaraf YG, Chen ZS, Ye W, Zhang D (2022) New insights into antiangiogenic therapy resistance in cancer: mechanisms and therapeutic aspects. Drug Resist Updat 64:100849. https://doi.org/10.1016/j.drup.2022.100849
Hussen BM, Salihi A, Abdullah ST, Rasul MF, Hidayat HJ, Hajiesmaeili M, Ghafouri-Fard S (2022) Signaling pathways modulated by miRNAs in Breast cancer angiogenesis and new therapeutics. Pathol Res Pract 230:153764. https://doi.org/10.1016/j.prp.2022.153764
Olejarz W, Kubiak-Tomaszewska G, Chrzanowska A, Lorenc T (2020) Exosomes in Angiogenesis and anti-angiogenic therapy in cancers. Int J Mol Sci 21. https://doi.org/10.3390/ijms21165840
You B, Cao X, Shao X, Ni H, Shi S, Shan Y, Gu Z, You Y (2016) Clinical and biological significance of HAX-1 overexpression in nasopharyngeal carcinoma. Oncotarget 7:12505–12524. https://doi.org/10.18632/oncotarget.7274
You B, Pan S, Gu M, Zhang K, **a T, Zhang S, Chen W, **e H, Fan Y, Yao H, Cheng T, Zhang P, Liu D, You Y (2022) Extracellular vesicles rich in HAX1 promote angiogenesis by modulating ITGB6 translation. J Extracell Vesicles 11:e12221. https://doi.org/10.1002/jev2.12221
Liu S, Wang J, Niu W, Liu E, Wang J, Peng C, Lin P, Wang B, Khan AQ, Gao H, Liang B, Shahbaz M, Niu J (2013) The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon Cancer. Cancer Lett 328:325–334. https://doi.org/10.1016/j.canlet.2012.10.004
Janes SM, Watt FM (2004) Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J Cell Biol 166:419–431. https://doi.org/10.1083/jcb.200312074
Mao X, Zhang X, Zheng X, Chen Y, Xuan Z, Huang P (2021) Curcumin suppresses LGR5(+) Colorectal cancer stem cells by inducing autophagy and via repressing TFAP2A-mediated ECM pathway. J Nat Med 75:590–601. https://doi.org/10.1007/s11418-021-01505-1
Gobin E, Bagwell K, Wagner J, Mysona D, Sandirasegarane S, Smith N, Bai S, Sharma A, Schleifer R, She JX (2019) A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. BMC Cancer 19:581. https://doi.org/10.1186/s12885-019-5768-0
Li Z, Biswas S, Liang B, Zou X, Shan L, Li Y, Fang R, Niu J (2016) Integrin β6 serves as an immunohistochemical marker for lymph node Metastasis and promotes cell invasiveness in cholangiocarcinoma. Sci Rep 6:30081. https://doi.org/10.1038/srep30081
Gao H, Peng C, Liang B, Shahbaz M, Liu S, Wang B, Sun Q, Niu Z, Niu W, Liu E, Wang J, Lin P, Wang J, Niu J (2014) β6 integrin induces the expression of metalloproteinase-3 and metalloproteinase-9 in colon Cancer cells via ERK-ETS1 pathway. Cancer Lett 354:427–437. https://doi.org/10.1016/j.canlet.2014.08.017
Assou S, Ahmed E, Morichon L, Nasri A, Foisset F, Bourdais C, Gros N, Tieo S, Petit A, Vachier I, Muriaux D, Bourdin A, De Vos J (2023) The Transcriptome Landscape of the In Vitro Human Airway Epithelium response to SARS-CoV-2. Int J Mol Sci 24. https://doi.org/10.3390/ijms241512017
Hu W, Hu Y, Pei Y, Li R, Xu F, Chi X, Mi J, Bergquist J, Lu L, Zhang L, Yang C (2023) Silencing DTX3L inhibits the progression of cervical carcinoma by regulating PI3K/AKT/mTOR signaling pathway. Int J Mol Sci 24. https://doi.org/10.3390/ijms24010861
Maher TM, Simpson JK, Porter JC, Wilson FJ, Chan R, Eames R, Cui Y, Siederer S, Parry S, Kenny J, Slack RJ, Sahota J, Paul L, Saunders P, Molyneaux PL, Lukey PT, Rizzo G, Searle GE, Marshall RP, Saleem A, Kang’ombe AR, Fairman D, Fahy WA, Vahdati-Bolouri M (2020) A positron emission tomography imaging study to confirm target engagement in the lungs of patients with Idiopathic Pulmonary Fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor. Respir Res 21:75. https://doi.org/10.1186/s12931-020-01339-7
Tu H, Liu H, Zhang L, Tan Z, Wang H, Jiang Y, **a Z, Guo L, **a X, Gu P, Liu X (2022) A novel prognostic model based on three integrin subunit genes-related signature for Bladder cancer. Front Oncol 12:970576. https://doi.org/10.3389/fonc.2022.970576
Safikhani Z, Smirnov P, Thu KL, Silvester J, El-Hachem N, Quevedo R, Lupien M, Mak TW, Cescon D, Haibe-Kains B (2017) Gene isoforms as expression-based biomarkers predictive of drug response in vitro. Nat Commun 8:1126. https://doi.org/10.1038/s41467-017-01153-8
**g C, Ma G, Li X, Wu X, Huang F, Liu K, Liu Z (2016) MicroRNA-17/20a impedes migration and invasion via TGF-β/ITGB6 pathway in esophageal squamous cell carcinoma. Am J Cancer Res 6:1549–1562
Ding X, Wang X, Zhao X, ** S, Tong Y, Ren H, Chen Z, Li Q (2015) RGD peptides protects against acute lung injury in septic mice through Wisp1-integrin β6 pathway inhibition. Shock (Augusta Ga) 43:352–360. https://doi.org/10.1097/shk.0000000000000313
Sun Q, Lu Z, Ma L, Xue D, Liu C, Ye C, Huang W, Dang Y, Li F (2023) Integrin β6 deficiency protects mice from experimental Colitis and colitis-associated carcinoma by altering macrophage polarization. Front Oncol 13:1190229. https://doi.org/10.3389/fonc.2023.1190229
Zhao P, Mao B, Cai X, Jiang J, Liu Z, Lin J, He X (2018) 2q24 deletion in a 9-month old girl with anal atresia, hearing impairment, and hypotonia. Int J Pediatr Otorhinolaryngol 109:96–100. https://doi.org/10.1016/j.ijporl.2018.03.031
Ducceschi M, Clifton LG, Stimpson SA, Billin AN (2014) Post-transcriptional regulation of ITGB6 protein levels in damaged skeletal muscle. J Mol Histol 45:329–336. https://doi.org/10.1007/s10735-014-9567-2
Funding
This work was supported by the National Natural Science Foundation of China (82200330, 82270526, and 82070422), China Postdoctoral Science Foundation (2022M722571), Research Plan Project of Shaanxi Institute of Basic Science (22JHQ053), High-end Foreign Expert Introduction Program of National Science and Technology (G2022040014L), Qinchuangyuan Traditional Chinese Medicine Innovation Research and Development Transformation Project (2022-QCYZH-036).
Author information
Authors and Affiliations
Contributions
H.Z. and Y.Y. conceives the concept and designs the outline. Z.Z. and Z.W. drafted manuscript. T.L., J.T., Y.L., and T.G. revised and edited the manuscript. K.C., L.W., and J.Z. contributed to picture design. All authors read and approve the final manuscript.
Corresponding authors
Ethics declarations
Ethical approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, Z., Wang, Z., Liu, T. et al. Exploring the role of ITGB6: fibrosis, cancer, and other diseases. Apoptosis 29, 570–585 (2024). https://doi.org/10.1007/s10495-023-01921-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-023-01921-6